Discover how leading drug discovery teams are combining structural biology, biophysics, and AI to accelerate therapeutic design, expand the druggable universe, and advance higher-quality candidates into development.
Position your organization alongside industry leaders including Sanofi, GSK, and AstraZeneca to connect with decision-makers actively investing in next-generation drug discovery technologies and partnerships.
Connect with experts in structural biology, biophysics, computational chemistry, AI, and emerging therapeutic modalities through dedicated networking, interactive discussions, and collaborative roundtable sessions designed to foster meaningful scientific partnerships.